From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...
So this is a drug that's still in development. So this is GS-1720. It's been studied as single doses in healthy volunteers ...
Hosted on MSN8h
Gilead reports positive HIV PrEP data for lenacapavirGilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...
Westport failed to provide a resident medication to treat advanced HIV for three weeks, resulting in "significant medication ...
People on MSN8d
Man Born with HIV Shares How He and His Wife Are Expecting an HIV-Negative Baby: 'I Was Able to Break a Cycle' (Exclusive)Joseph Kibler and his wife, Carey Cox, shared that they're expecting a baby who will be HIV-negative, despite Kibler's ...
12hon MSNOpinion
Yet, even as life expectancy increases, our healthcare system is struggling to catch up with the unique needs of ageing ...
WSAV Savannah on MSN5h
World AIDs Day: Coastal Health District to offer free HIV testing events in SavannahIn honor of World AIDs Day, the Coastal Health District (CHD) is offering three free HIV testing events in Savannah. At two ...
The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...
Serious questions are being raised about what led to the limited supply of crucial HIV medication, prompting the Health ...
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...
HIV is an infection that can be transmitted from one person to another through sexual activity, such as anal, oral, or ...
(HealthDay News) — The supply of health care professionals available to provide HIV care is expected to continue to decline over the next 5 years, according to research published in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback